Redwire Announces First Spaceflight Mission for New Cutting-Edge Pharmaceutical Drug Development Lab, Partnering with Eli Lilly and Company to Expand Space Research to Study Heart Disease and Diabetes
30 Outubro 2023 - 8:30AM
Business Wire
Redwire Corporation (NYSE: RDW), a leader in space
infrastructure for the next generation space economy, announced
today the first spaceflight mission for its cutting-edge in-space
pharmaceutical manufacturing platform, PIL-BOX, designed to offer
pharmaceutical companies and researchers novel and flexible
services to grow small-batch crystals of protein-based
pharmaceuticals and other key pharmaceutically relevant molecules
for research. The new platform will launch onboard SpaceX’s 29th
cargo resupply services mission (SpaceX-29) for NASA to the
International Space Station (ISS).
On the inaugural PIL-BOX-01 mission, Eli Lilly and Company
(Lilly) is partnering with Redwire to conduct three critical
experiments focused on developing advanced treatments for diabetes,
cardiovascular disease, and pain.
“The microgravity environment is a game changer for
pharmaceutical drug development, which has a greater than $240
billion annual spend in 2022, and has tremendous potential to save
and improve life on Earth,” said Redwire Executive Vice President
John Vellinger. “PIL-BOX presents us with a brand-new capability
for developing critical, life-saving treatments, like insulin, for
diseases like diabetes and heart disease. With PIL-BOX, Redwire is
providing a critical capability for researchers and enabling them
to develop novel forms of crystals to create better, more
successful treatments for patients.”
Understanding crystal growth and design can inform the entire
drug development and design process as pharmaceutical companies
look to deliver new, optimized treatments to help patients on
Earth. Previous spaceflight investigations indicate that growing
crystals in space could yield a more uniform product with fewer
imperfections, which can improve the drug discovery and development
process.
PIL-BOX technology builds from Redwire’s multi-decade space
crystallization flight heritage, which dates back to the space
shuttle era through its Advanced Space Experiment Processor.
PIL-BOX is being developed in partnership with NASA, through its In
Space Production Applications flight demonstrations program, which
is focused on stimulating demand in low-Earth orbit.
On SpaceX-29, Redwire is also launching materials for an
investigation that will bioprint cardiac tissue on orbit using
Redwire’s BioFabrication Facility (BFF). This type of technology
could be used to develop heart patches that can be applied to the
outside of damaged hearts and advances our ability to print
complex, thick tissues that cannot be produced on Earth. In
September, Redwire announced that it had successfully 3D bioprinted
the first human knee meniscus on orbit using BFF. The print
returned to Earth for further study and analysis.
PIL-BOX and BFF are part of Redwire’s broad portfolio of space
biotech and microgravity development capabilities targeting the use
of the unique environment in space to enhance life on Earth.
About Redwire
Redwire Corporation (NYSE: RDW) is a global leader in mission
critical space solutions and high reliability components for the
next generation space economy, with valuable intellectual property
for solar power generation, in-space 3D printing and manufacturing,
avionics, critical components, sensors, digital engineering and
space-based biotechnology. It combines decades of flight heritage
with an agile and innovative culture. The company’s “Heritage plus
Innovation” strategy enables it to combine proven performance with
new, innovative capabilities to provide its customers with the
building blocks for the present and future of space infrastructure.
For more information, please visit redwirespace.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231030082093/en/
Media Contact: Emily Devine Emily.Devine@redwirespace.com
305-632-9137 OR Investors:
investorrelations@redwirespace.com 904-425-1431
Redwire (NYSE:RDW)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Redwire (NYSE:RDW)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024